1. United Kingdom Government . Patients admitted to hospital. Available: https://coronavirus.data.gov.uk/details/healthcare?areaType=overview&areaName=United%20Kingdom#card-patients_admitted_to_hospital [Accessed 21 Feb 2022].
2. Randomised evaluation of COVID-19 therapy. results. Available: https://www.recoverytrial.net/results [Accessed 21 Feb 2022].
3. Medicines & Healthcare products Regulatory Agency . Summary of product characteristics for Ronapreve. Available: https://www.gov.uk/government/publications/regulatory-approval-of-ronapreve/summary-of-product-characteristics-for-ronapreve [Accessed 21 Feb 2022].
4. Department of Health & Social Care . Antibody testing for SARS-CoV-2: key information. Available: https://www.gov.uk/government/publications/antibody-testing-for-sars-cov-2-key-information/antibody-testing-for-sars-cov-2-information-for-general-practitioners [Accessed 21 Feb 2022].
5. Randomised Evaluation of COVID-19 Therapy (RECOVERY) . RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response. Available: https://www.recoverytrial.net/news/recovery-trial-finds-regeneron2019s-monoclonal-antibody-combination-reduces-deaths-for-hospitalised-covid-19-patients-who-have-not-mounted-their-own-immune-response-1 [Accessed 21 Feb 2022].